A previously healthy octogenarian presented with new onset heart failure symptoms. Comprehensive multimodality imaging including complete echocardiography with longitudinal strain analysis, cardiac magnetic resonance imaging (cMRI), nuclear medicine pyrophosphate (99-mcTcPYP) scan along with biomarker, monoclonal protein analysis, and fat pad biopsy confirmed diagnosis of transthyretin cardiac amyloidosis
Systemic amyloidosis encompasses a debilitating, under-diagnosed but increasingly recognized group o...
SummaryAlthough primary cardiac amyloidosis is a rare affliction of the heart, its clinical and path...
IntroductionAmyloidosis is a rare disease. Some types of amyloidosis may significantly affect the he...
International audienceAmyloidosis is a severe systemic disease. Cardiac involvement may occur in the...
SummaryAmyloidosis is a severe systemic disease. Cardiac involvement may occur in the three main typ...
Heart failure has proven to be a major health problem in the United States contributing to significa...
Cardiac amyloidosis (CA) is a progressive cardiomyopathy in which misfolded endogenous proteins form...
Cardiac amyloidosis (CA) is a progressive cardiomyopathy in which misfolded endogenous proteins form...
Amyloidosis is a complex group of disorders that can involve many organs and cause their dysfunction...
Cardiac amyloidosis is an increasingly recognized entity that causes significant morbidity and morta...
Amyloidosis is a systemic infiltrative disease, in which unstable proteins misfold, form aggregates ...
Cardiac amyloidosis (CA) is increasingly diagnosed due to the advancements made in diagnostics and t...
BACKGROUND: Hypertrophic cardiomyopathy (HCM) and cardiac amyloidosis are pathologically distinct di...
Abstract Restrictive cardiomyopathy secondary to cardiac amyloidosis is an underdiagnosed, but treat...
Cardiac amyloidosis is a condition when amyloid fibers are deposited in the extracellular space of t...
Systemic amyloidosis encompasses a debilitating, under-diagnosed but increasingly recognized group o...
SummaryAlthough primary cardiac amyloidosis is a rare affliction of the heart, its clinical and path...
IntroductionAmyloidosis is a rare disease. Some types of amyloidosis may significantly affect the he...
International audienceAmyloidosis is a severe systemic disease. Cardiac involvement may occur in the...
SummaryAmyloidosis is a severe systemic disease. Cardiac involvement may occur in the three main typ...
Heart failure has proven to be a major health problem in the United States contributing to significa...
Cardiac amyloidosis (CA) is a progressive cardiomyopathy in which misfolded endogenous proteins form...
Cardiac amyloidosis (CA) is a progressive cardiomyopathy in which misfolded endogenous proteins form...
Amyloidosis is a complex group of disorders that can involve many organs and cause their dysfunction...
Cardiac amyloidosis is an increasingly recognized entity that causes significant morbidity and morta...
Amyloidosis is a systemic infiltrative disease, in which unstable proteins misfold, form aggregates ...
Cardiac amyloidosis (CA) is increasingly diagnosed due to the advancements made in diagnostics and t...
BACKGROUND: Hypertrophic cardiomyopathy (HCM) and cardiac amyloidosis are pathologically distinct di...
Abstract Restrictive cardiomyopathy secondary to cardiac amyloidosis is an underdiagnosed, but treat...
Cardiac amyloidosis is a condition when amyloid fibers are deposited in the extracellular space of t...
Systemic amyloidosis encompasses a debilitating, under-diagnosed but increasingly recognized group o...
SummaryAlthough primary cardiac amyloidosis is a rare affliction of the heart, its clinical and path...
IntroductionAmyloidosis is a rare disease. Some types of amyloidosis may significantly affect the he...